Virginia Urology Center

Richmond, Virginia 23235

0 studies enrolling now · 13 studies all time

What they study most

Bladder Cancer, Nocturia, Prostate Cancer, Prostatic Neoplasms, Urinary Bladder, Overactive, Urinary Incontinence

Studies at this site

• Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer — Completed
• A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer — Status unconfirmed
• Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence — Completed
• PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• A Study of Degarelix in Patients With Prostate Cancer — Completed
• Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia — Completed
• A Trial of Degarelix in Patients With Prostate Cancer — Completed
• Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer — Status unconfirmed
• Eflornithine in Treating Patients With Bladder Cancer — Completed
• Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer — Status unconfirmed
• A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer — Completed
• Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer — Completed
• A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed